Last Update Time: 17-Mar-2025 16:00:00
ISIN: INE065X01017
Sector: Healthcare
Symbol: INDGN

Indegene Limited

₹525.60 ₹12.30 (2.40%) ▲
Prev. Close ₹513.30
Open ₹515.15
Close ₹524.30
Range ₹499.32 - ₹551.88
High ₹527.00
Low ₹515.05
Ind. Close ₹0.00
VWAP ₹523.74

The current stock price of Indegene Limited is ₹525.60, with a target price range between ₹499.32 and ₹551.88. The stock has experienced a price change of ₹12.30 (2.40%), reflecting recent market volatility.

Today's opening price was ₹515.15, while the previous close stood at ₹513.30.

The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.

For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.

Indegene Limited Price Chart

Indegene Limited Pre Open Market Overview: 17-Mar-2025

Key Metrics:

  • IEP (Indicative Equilibrium Price): 515.15
  • Previous Close Price: 513.3
  • Change: 1.85%
  • Total Traded Volume: 715
  • Total Buy Quantity: 10,663
  • Total Sell Quantity: 66,217
PriceBuy QtySell Qty
513.0015.000.00
513.3035.000.00
514.0050.000.00
515.0095.000.00
515.05200.000.00
515.150.0030.00
516.050.00219.00
516.800.0044.00
517.100.00219.00
518.150.00219.00

ATO Data:

  • Buy Quantity (ATO): 0
  • Sell Quantity (ATO): 0

Order Book

BidQtyAskQty
0.0000.000
0.0000.000
0.0000.000
0.0000.000
0.0000.000
Total Buy Quantity: 10663 Total Sell Quantity: 66217

Shareholding Patterns of Indegene Limited

Key Trade Statistics of Indegene Limited

Trade InformationDetails
Traded Volume (Lakhs)6.53
Traded Value (₹ Cr.)34.22
Total Market Cap (₹ Cr.)12,597.45
Free Float Market Cap (₹ Cr.)2,461.05
Impact cost0.07
Quantity Traded653,421.00
Deliverable Quantity425,608.00
% of Quantity to Traded65.14
Security VaR15.29
Index VaRN/A
VaR Margin15.29
Extreme Loss Rate3.5
Adhoc MarginN/A
Applicable Margin Rate18.79
Face Value2

Key Price Statistics of Indegene Limited

The 52-week high for Indegene Limited was ₹736.30, recorded on 01-Oct-2024. On the other hand, the 52-week low stands at ₹470.10, with the lowest value recorded on 04-Jun-2024.

The upper band for trading is ₹615.95, and the lower band is ₹410.65. The price band is 20%.

The stock's daily volatility stands at 2.37, while the annualized volatility is 45.28. The tick size for trading is ₹0.05.

Price InformationDetails
52 Week High (01-Oct-2024)736.30
52 Week Low (04-Jun-2024)470.10
Upper Band615.95
Lower Band410.65
Price Band (%)20
Daily Volatility2.37
Annualised Volatility45.28
Tick Size0.05

Key Securities Statistics of Indegene Limited

Securities InformationDetails
StatusListed
Trading StatusActive
Date of Listing13-May-2024
Adjusted P/E32.23
Symbol P/E32.05
IndexNIFTY 500
Macro-Economic SectorHealthcare
SectorHealthcare
IndustryHealthcare Services
Basic IndustryHealthcare Research Analytics & Technology

Security Status of Indegene Limited

TitleDetails
Board StatusMain
Trading SegmentNormal Market
Session No.-
Class of SharesEquity
SDD Compliance-
Name of Compliance Officer-

Announcements of Indegene Limited

SubjectDate
Notice Of Shareholders Meetings-XBRL 17-Mar-2025
Shareholders meeting 17-Mar-2025
Alteration Of Capital and Fund Raising-XBRL 14-Mar-2025
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent 14-Mar-2025
General Updates 13-Mar-2025
Analysts/Institutional Investor Meet/Con. Call Updates 10-Mar-2025
Press Release 10-Mar-2025
Updates 06-Mar-2025

Corporate Actions of Indegene Limited

Face ValuePurposeEx-DateStart DateEnd Date
2Annual General Meeting29-Aug-202430-Aug-202406-Sep-2024

Board Meetings of Indegene Limited

PurposeDetailsAtt.Mtg. Date
Board Meeting IntimationINDEGENE LIMITED has informed the Exchange about Board Meeting to be held on 30-Jan-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and ESOP/Other business. 30-Jan-2025
Financial Results/Other business mattersTo consider and approve the financial results for the period ended December 31, 2024 and other business matters 30-Jan-2025
INDEGENE LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .Board Meeting Intimation 28-Oct-2024
Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024 28-Oct-2024
INDEGENE LIMITED has informed the Exchange about Board Meeting to be held on 01-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .Board Meeting Intimation 01-Aug-2024
Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2024 01-Aug-2024
Financial ResultsTo consider and approve the financial results for the period ended March 31, 2024 29-May-2024

Financial Results of Indegene Limited

Company Directory of Indegene Limited

Web AddressSM NameOfficeAddressCityPincodeTelephoneEmail
N/AIndegene LimitedHead Office/ Corporate Office7/6, BRUNTON ROAD
Bengaluru Urban
BANGALORE56002591-996223599compliance.officer@indegene.com
N/AIndegene LimitedRegistered OfficeAspen Block G4, 3rd Floor
Manyata Embassy Business Park
Outer Ring Road, Nagawara
BANGALORE56004591-08046744567compliance.officer@indegene.com

Insider Trading of Indegene Limited

Reg. ClauseAcq./Disp.Sec. (No.)Sec. ValueTxn TypeBcast Time
7(2)Manish Gupta1700010186185Buy27-Dec-2024 21:41
7(2)Sanjay Suresh Parikh1650010007649Buy23-Dec-2024 23:06
7(2)Rajesh Bhaskaran Nair2500014956597Buy23-Dec-2024 23:06
7(2)Rajesh Bhaskaran Nair10000059580954Buy18-Dec-2024 19:29
7(2)Viveksheel A. Ghai2000012552741Sell05-Dec-2024 21:52
7(2)Suhas Prabhu620417068Sell28-Sep-2024 15:03
7(2)Suhas Prabhu4938033054953Sell28-Sep-2024 15:03

Annual Reports of Indegene Limited

CompanyFrom YearTo YearAtt.
Indegene Limited20232024

Investor Complaints of Indegene Limited

Event Calendar of Indegene Limited

CompanyPurposeDetailsDate
Indegene LimitedFinancial ResultsTo consider and approve the financial results for the period ended March 31, 202429-May-2024
Indegene LimitedFinancial ResultsTo consider and approve the financial results for the period ended Jun 30, 202401-Aug-2024
Indegene LimitedFinancial ResultsTo consider and approve the financial results for the period ended September 30, 202428-Oct-2024
Indegene LimitedFinancial Results/Other business mattersTo consider and approve the financial results for the period ended December 31, 2024 and other business matters30-Jan-2025

Share Transfers of Indegene Limited

CompanyPeriodReg.7Reg.40Reg7 Bcast DateReg40 Bcast Date
No Share Transfer data available

Voting Results of Indegene Limited

Date of Mtg.Mtg. TypeResolutionR. requiredTotal SHs% favour% against
06-SEP-2024AGMADOPTION OF FINANCIAL STATEMENTSOrdinary1725131000
06-SEP-2024AGMAPPOITNMENT OF DR. SANJAY SURESH PARIKH AS A DIRECTOR, LIABLE TO RETIRE BY ROTATIONOrdinary17251397.482.52
06-SEP-2024AGMAPPOINTMENT OF MR. NEERAJ BHARADWAJ AS A DIRECTOR, LIABLE TO RETIRE BY ROTATIONSpecial17251399.550.45
06-SEP-2024AGMTO RATIFY INDEGENE LIMITED EMPLOYEE STOCK OPTION PLAN (ESOP 2020/PLAN)INCLUDING THE INDEGENE LIMITED COMPANY SHARE OPTION CSOP 2022 (CSOP SUB -PLAN FOR INDEGENE LIMITED)Special17251399.250.75
06-SEP-2024AGMTO RATIFY INDEGENE LIMITED EMPLOYEE STOCK OPTION PLAN 2020 (ESOP 2020/PLAN)INCLUDING THE INDEGENE LIMITED COMPANY SHARE OPTION CSOP 2022 ( CSOP SUB -PLAN) FOR THE SUBSIDIARIES OF INDEGENE LIMITEDSpecial17251399.250.75
06-SEP-2024AGMTO RATIFY THE INDEGENE EMPLOYEE RESTRICTED STOCK UNIT PLAN 2020 (RSU 2020/PLAN) FOR INDEGENE LIMITEDSpecial17251398.441.56
06-SEP-2024AGMTO RATIFY THE INDEGENE EMPLOYEE RESTRICTED STOCK UNIT PLAN 2020 (RSU 2020/PLAN)FOR THE SUBSIDIARIES OF INDEGENE LIMITEDSpecial17251398.441.56
06-SEP-2024AGMAPPOINTMENT OF MR. KRISHNAMURTHY VENUGOPALA TENNETISpecial17251395.964.04
06-SEP-2024AGMGRANTING NOMINATION RIGHTS TO SPECIFIC SHAREHOLDERSSpecial17251397.282.72

FAQs on Indegene Limited

Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.